+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English
Global Oral Thin Film Drugs Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Oral Thin Film Drugs Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application


  • Publish date: 2018-08-05  | 
  • Pages: 131  | 
  • Tables: 164  | 
  • Hits: 13

  • Report Id: 483623  | 
  • Report Category: Pharma & Healthcare
  • Publish date: 2018-08-05  | 
  • Pages: 131
  • Tables: 164  | 
  • Hits: 13
Summary

This report studies the Oral Thin Film Drugs market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The global Oral Thin Film Drugs market was million US$ in 2017 and is expected to million US$ by the end of 2025, growing at a CAGR of between 2018 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oral Thin Film Drugs in these regions, from 2013 to 2025, covering

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

    South America (Brazil etc.)

    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

    Sumitomo Dainippon Pharma Co., Ltd.

    Pfizer, Inc.

    Novartis AG

    ZIM Laboratories Limited

    Indivior Plc.

    Allergan Plc.

    IntelGenx Corp

    NAL Pharma

    Wolters Kluwer

By the product type, the market is primarily split into

    Sublingual Film

    Fully Dissolving Dental/Buccal Film

By the end users/application, this report covers the following segments

    Schizophrenia

    Migraine

    Opioid Dependence

    Nausea & Vomiting

    Others

We can also provide the customized separate regional or country-level reports, for the following regions:

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

        Rest of Asia-Pacific

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

        Rest of Europe

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

        Rest of Middle East & Africa

The study objectives of this report are:

    To study and analyze the global Oral Thin Film Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Oral Thin Film Drugs market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Oral Thin Film Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Oral Thin Film Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Oral Thin Film Drugs submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oral Thin Film Drugs are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Thin Film Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Oral Thin Film Drugs market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

In spite of political and economic instability in the recent past, pharmaceutical and healthcare industry is booming across the globe. Cutting edge technology in medical devices, reformation in biotech & pharmaceuticals, and remarkable growth in the geriatric population are some of the important reasons behind rapidly flourishing healthcare and pharmaceutical industry.

QY Research has offered a comprehensive assessment of the markets in the pharmaceutical & healthcare industry in its recently published research report. This evaluation is done on the basis of historical data, quantitative & qualitative insights and flexible projections about the size of the market. As per the requirement of pharmaceutical and healthcare industry, various techniques are used on an experimental basis to make this report an exclusive one. These techniques are patient-level data, insights on medical technology & devices and comprehensive data on a number of procedures.

Strategies of top players in the pharmaceutical and healthcare industry

QY Research has provided thorough information from vendors along with a complete analysis of the performance of leading players across the globe operating in the pharmaceutical and healthcare industry. One of the important aspects covered in this report is an in-depth evaluation of various markets fall under the purview of the pharmaceutical and healthcare industry and its growth prospects in the years to come. This research report has also included the ideas exchanged between analysts and key players functioning in the industry. 

QY Research has also offered an easily navigable platform which will help clients in assessing their as well as their competitive vendors’ value. This unique feature provided by QY Research would not only help top players in the market in placing their strategies but will also guide them in successfully achieving their targets in the extremely competitive market.

Analysis of market taxonomy   

The markets covered under the purview of the pharmaceutical and healthcare sector are generally segmented as, by product, by application, by end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.

Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, bottom-up approach has been used by the experts in pharmaceutical and healthcare sector. While examining different segments of the markets in the pharmaceutical and healthcare industry, the analysts in QY Research have carried out several surveys along with detailed primary research.

Regional Analysis

This research report has presented various market segments with an in-depth analysis of key regions. Based on the regions the market is classified into the Middle East and Africa, Eastern & Western Europe, Latin America, the Asia Pacific including Japan and North America. The regional splits of the entire market along with its sub-segments are based on the use of the particular product in the respective regions or countries.

The research analysts in QY Research went the extra mile to provide detail information about the scope of industries in countries such as the United States, Brazil, China, Japan, Malaysia, India and South Korea. There is a huge demand for dietary supplements, veterinary drugs, medicines, human and veterinary vaccines, and blood products across the globe.

North America and Europe region, in particular, have witnessed a large demand for these products because of growing disposable income and thereby improving lifestyle. Due to increasing demands for the pharmaceutical and healthcare products, Gross Domestic Product of the regions and countries has increased and it has led to the market revenue which turns into an increase in the economy of the countries.

Lucid and coherent research reports are the forte of QY Research

For easy and better understanding and organization of the report, experts have classified the report based on the pharmaceutical and healthcare sector in three parts. The first part of the research report consists of an overview of the report which is generally known as the introduction section. This section contains a market viewpoint and in-depth information about the concerned product. 

The second part of the report includes market dynamics such as trends, drivers, restraints and various opportunities. Comprehensive information about pricing analysis is also a part of this section. Regional analysis is provided in the third part of the report.

One of its kind research methodology

The dedicated team of analysts have initially conducted primary research that include various demand-side users such as surgeons, chief opinion leaders, and physicians, while the participants from supply-side providers of various medical devices have offered valuable inputs on patient education, competitive dynamics and pricing, manufacturers and their significant strategies and development of medical devices.

To recognize the viability of the target category of technologies or products and its respective product offerings, segments, the lifespan of various medical devices and to target various healthcare facilities, QY Research has carried out secondary research. Thus each and every piece of information is gradually evaluated over the course of a research project that builds a solid base for secondary as well as primary research.

It is to be noted that these are just initial steps that are being followed by the research team of QY Research. Apart from this, to make this report an exclusive one analysts have done the forecasting based on internal methodology and models developed in QY Research that uses various macro-economic factors such as per capita income and healthcare expenditure.

QY Research, offers detail analysis, research, forecasts and data through the team of market analysts, consultants and industry experts in the process, ensuring the reliability of information through a multi-check audit process. QY Research provides advanced industry-specific models that are used in order to ensure accuracy and completeness of data


READ MORE
Table of Contents

1 Oral Thin Film Drugs Market Overview

    1.1 Oral Thin Film Drugs Product Overview

    1.2 Oral Thin Film Drugs Market Segment by Type

        1.2.1 Sublingual Film

        1.2.2 Fully Dissolving Dental/Buccal Film

    1.3 Global Oral Thin Film Drugs Market Size by Type

        1.3.1 Global Oral Thin Film Drugs Sales and Growth by Type

        1.3.2 Global Oral Thin Film Drugs Sales and Market Share by Type (2013-2018)

        1.3.3 Global Oral Thin Film Drugs Revenue and Market Share by Type (2013-2018)

        1.3.4 Global Oral Thin Film Drugs Price by Type (2013-2018)

2 Global Oral Thin Film Drugs Market Competition by Company

    2.1 Global Oral Thin Film Drugs Sales and Market Share by Company (2013-2018)

    2.2 Global Oral Thin Film Drugs Revenue and Share by Company (2013-2018)

    2.3 Global Oral Thin Film Drugs Price by Company (2013-2018)

    2.4 Global Top Players Oral Thin Film Drugs Manufacturing Base Distribution, Sales Area, Product Types

    2.5 Oral Thin Film Drugs Market Competitive Situation and Trends

        2.5.1 Oral Thin Film Drugs Market Concentration Rate

        2.5.2 Global Oral Thin Film Drugs Market Share of Top 5 and Top 10 Players

        2.5.3 Mergers & Acquisitions, Expansion

3 Oral Thin Film Drugs Company Profiles and Sales Data

    3.1 Sumitomo Dainippon Pharma Co., Ltd.

        3.1.1 Company Basic Information, Manufacturing Base and Competitors

        3.1.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.1.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.1.4 Main Business Overview

    3.2 Pfizer, Inc.

        3.2.1 Company Basic Information, Manufacturing Base and Competitors

        3.2.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.2.3 Pfizer, Inc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.2.4 Main Business Overview

    3.3 Novartis AG

        3.3.1 Company Basic Information, Manufacturing Base and Competitors

        3.3.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.3.3 Novartis AG Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.3.4 Main Business Overview

    3.4 ZIM Laboratories Limited

        3.4.1 Company Basic Information, Manufacturing Base and Competitors

        3.4.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.4.3 ZIM Laboratories Limited Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.4.4 Main Business Overview

    3.5 Indivior Plc.

        3.5.1 Company Basic Information, Manufacturing Base and Competitors

        3.5.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.5.3 Indivior Plc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.5.4 Main Business Overview

    3.6 Allergan Plc.

        3.6.1 Company Basic Information, Manufacturing Base and Competitors

        3.6.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.6.3 Allergan Plc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.6.4 Main Business Overview

    3.7 IntelGenx Corp

        3.7.1 Company Basic Information, Manufacturing Base and Competitors

        3.7.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.7.3 IntelGenx Corp Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.7.4 Main Business Overview

    3.8 NAL Pharma

        3.8.1 Company Basic Information, Manufacturing Base and Competitors

        3.8.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.8.3 NAL Pharma Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.8.4 Main Business Overview

    3.9 Wolters Kluwer

        3.9.1 Company Basic Information, Manufacturing Base and Competitors

        3.9.2 Oral Thin Film Drugs Product Category, Application and Specification

        3.9.3 Wolters Kluwer Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin(2013-2018)

        3.9.4 Main Business Overview

4 Oral Thin Film Drugs Market Status and Outlook by Regions

    4.1 Global Market Status and Outlook by Regions

        4.1.1 Global Oral Thin Film Drugs Market Size and CAGR by Regions

        4.1.2 North America

        4.1.3 Asia-Pacific

        4.1.4 Europe

        4.1.5 South America

        4.1.6 Middle East and Africa

    4.2 Global Oral Thin Film Drugs Sales and Revenue by Regions

        4.2.1 Global Oral Thin Film Drugs Sales and Market Share by Regions (2013-2018)

        4.2.2 Global Oral Thin Film Drugs Revenue and Market Share by Regions (2013-2018)

        4.2.3 Global Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

    4.3 North America Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin

        4.3.1 United States

        4.3.2 Canada

        4.3.3 Mexico

    4.4 Europe Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin

        4.4.1 Germany

        4.4.2 UK

        4.4.3 France

        4.4.4 Italy

        4.4.5 Russia

        4.4.6 Turkey

    4.5 Asia-Pacific Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin

        4.5.1 China

        4.5.2 Japan

        4.5.3 Korea

        4.5.4 Southeast Asia

            4.5.4.1 Indonesia

            4.5.4.2 Thailand

            4.5.4.3 Malaysia

            4.5.4.4 Philippines

            4.5.4.5 Vietnam

        4.5.5 India

        4.5.6 Australia

    4.6 South America Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin

        4.6.1 Brazil

    4.7 Middle East and Africa Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin

        4.7.1 Egypt

        4.7.2 GCC Countries

5 Oral Thin Film Drugs Application/End Users

    5.1 Oral Thin Film Drugs Segment by Application

        5.1.1 Schizophrenia

        5.1.2 Migraine

        5.1.3 Opioid Dependence

        5.1.4 Nausea & Vomiting

        5.1.5 Others

    5.2 Global Oral Thin Film Drugs Product Segment by Application

        5.2.1 Global Oral Thin Film Drugs Sales by Application

        5.2.2 Global Oral Thin Film Drugs Sales and Market Share by Application (2013-2018)

6 Global Oral Thin Film Drugs Market Forecast

    6.1 Global Oral Thin Film Drugs Sales, Revenue Forecast (2018-2025)

        6.1.1 Global Oral Thin Film Drugs Sales and Growth Rate Forecast (2018-2025)

        6.1.1 Global Oral Thin Film Drugs Revenue and Growth Rate Forecast (2018-2025)

    6.2 Global Oral Thin Film Drugs Forecast by Regions

        6.2.1 North America Oral Thin Film Drugs Sales and Revenue Forecast (2018-2025)

        6.2.2 Europe Oral Thin Film Drugs Sales and Revenue Forecast (2018-2025)

        6.2.3 Asia-Pacific Oral Thin Film Drugs Sales and Revenue Forecast (2018-2025)

            6.2.3.1 China

            6.2.3.2 Japan

            6.2.3.3 Korea

            6.2.3.4 Southeast Asia

            6.2.3.5 India

            6.2.3.6 Australia

        6.2.4 South America Oral Thin Film Drugs Sales and Revenue Forecast (2018-2025)

        6.2.5 Middle East and Africa Oral Thin Film Drugs Sales and Revenue Forecast (2018-2025)

            6.2.5.1 Egypt

            6.2.5.2 GCC Countries

    6.3 Oral Thin Film Drugs Forecast by Type

        6.3.1 Global Oral Thin Film Drugs Sales and Revenue Forecast by Type (2018-2025)

        6.3.2 Sublingual Film Gowth Forecast

        6.3.3 Fully Dissolving Dental/Buccal Film Gowth Forecast

    6.4 Oral Thin Film Drugs Forecast by Application

        6.4.1 Global Oral Thin Film Drugs Sales Forecast by Application (2018-2025)

        6.4.2 Global Oral Thin Film Drugs Forecast in Schizophrenia

        6.4.3 Global Oral Thin Film Drugs Forecast in Migraine

7 Oral Thin Film Drugs Upstream Raw Materials

    7.1 Oral Thin Film Drugs Key Raw Materials

        7.1.1 Key Raw Materials

        7.1.2 Key Raw Materials Price

        7.1.3 Raw Materials Key Suppliers

    7.2 Manufacturing Cost Structure

        7.2.1 Raw Materials

        7.2.2 Labor Cost

        7.2.3 Manufacturing Expenses

    7.3 Oral Thin Film Drugs Industrial Chain Analysis

8 Marketing Strategy Analysis, Distributors

    8.1 Marketing Channel

        8.1.1 Direct Marketing

        8.1.2 Indirect Marketing

        8.1.3 Marketing Channel Development Trend

    8.2 Distributors

    8.3 Downstream Customers

9 Research Findings and Conclusion

Appendix

    Methodology/Research Approach

        Research Programs/Design

        Market Size Estimation

        Market Breakdown and Data Triangulation

    Data Source

        Secondary Sources

        Primary Sources

    Disclaimer

List of Tables and Figures

    Figure Oral Thin Film Drugs Product Picture

    Figure Global Oral Thin Film Drugs Revenue (Million USD) Status and Outlook (2013-2025)

    Figure Global Oral Thin Film Drugs Sales (K Doses) Status and Outlook (2013-2025)

    Figure Product Picture of Sublingual Film

    Table Major Players of Sublingual Film

    Figure Global Sublingual Film Sales (K Doses) and Growth Rate (%)(2013-2018)

    Figure Product Picture of Fully Dissolving Dental/Buccal Film

    Table Major Players of Fully Dissolving Dental/Buccal Film

    Figure Global Fully Dissolving Dental/Buccal Film Sales (K Doses) and Growth Rate (%)(2013-2018)

    Table Global Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Comparison by Type

    Table Global Oral Thin Film Drugs Sales (K Doses) by Type (2013-2018)

    Table Global Oral Thin Film Drugs Sales Share (%) by Type (2013-2018)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) by Type (2013-2018)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) by Type in 2017

    Table Global Oral Thin Film Drugs Revenue (Million USD) by Type (2013-2018)

    Table Global Oral Thin Film Drugs Revenue Share (%) by Type (2013-2018)

    Figure Global Oral Thin Film Drugs Revenue Share (%) by Type (2013-2018)

    Figure 2017 Global Oral Thin Film Drugs Revenue Market Share (%) by Type

    Table Global Oral Thin Film Drugs Price (USD/Dose) by Type (2013-2018)

    Table Global Oral Thin Film Drugs Sales (K Doses) by Company (2013-2018)

    Table Global Oral Thin Film Drugs Sales Share (%) by Company (2013-2018)

    Figure Global Oral Thin Film Drugs Sales Share (%) by Company in 2017

    Table Global Oral Thin Film Drugs Revenue (Million USD) by Company (2013-2018)

    Table Global Oral Thin Film Drugs Revenue Share (%) by Company (2013-2018)

    Figure Global Oral Thin Film Drugs Revenue Share (%) by Company in 2017

    Table Global Market Oral Thin Film Drugs Average Price (USD/Dose) by Company (2013-2018)

    Table Global Oral Thin Film Drugs Top Players Manufacturing Base Distribution and Sales Area

    Table Global Oral Thin Film Drugs Top Players Product Category

    Figure Global Oral Thin Film Drugs Market Share (%) of Top 5 Players

    Figure Global Oral Thin Film Drugs Market Share (%) of Top 10 Players

    Table Sumitomo Dainippon Pharma Co., Ltd. Basic Information List

    Table Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Product Category, Application and Specification

    Table Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table Pfizer, Inc. Basic Information List

    Figure Pfizer, Inc. Oral Thin Film Drugs Product Category, Application and Specification

    Table Pfizer, Inc. Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Pfizer, Inc. Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure Pfizer, Inc. Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table Novartis AG Basic Information List

    Figure Novartis AG Oral Thin Film Drugs Product Category, Application and Specification

    Table Novartis AG Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Novartis AG Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure Novartis AG Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table ZIM Laboratories Limited Basic Information List

    Figure ZIM Laboratories Limited Oral Thin Film Drugs Product Category, Application and Specification

    Table ZIM Laboratories Limited Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure ZIM Laboratories Limited Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure ZIM Laboratories Limited Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table Indivior Plc. Basic Information List

    Figure Indivior Plc. Oral Thin Film Drugs Product Category, Application and Specification

    Table Indivior Plc. Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Indivior Plc. Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure Indivior Plc. Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table Allergan Plc. Basic Information List

    Figure Allergan Plc. Oral Thin Film Drugs Product Category, Application and Specification

    Table Allergan Plc. Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Allergan Plc. Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure Allergan Plc. Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table IntelGenx Corp Basic Information List

    Figure IntelGenx Corp Oral Thin Film Drugs Product Category, Application and Specification

    Table IntelGenx Corp Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure IntelGenx Corp Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure IntelGenx Corp Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table NAL Pharma Basic Information List

    Figure NAL Pharma Oral Thin Film Drugs Product Category, Application and Specification

    Table NAL Pharma Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure NAL Pharma Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure NAL Pharma Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table Wolters Kluwer Basic Information List

    Figure Wolters Kluwer Oral Thin Film Drugs Product Category, Application and Specification

    Table Wolters Kluwer Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Wolters Kluwer Oral Thin Film Drugs Sales Growth Rate (2013-2018)

    Figure Wolters Kluwer Oral Thin Film Drugs Sales Global Market Share (%)(2013-2018)

    Table Global Oral Thin Film Drugs Market Size Comparison by Regions (2013-2025)

    Figure North America Oral Thin Film Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure Asia-Pacific Oral Thin Film Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure Europe Oral Thin Film Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure South America Oral Thin Film Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Figure Middle East and Africa Oral Thin Film Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

    Table Global Oral Thin Film Drugs Sales (K Doses) by Regions (2013-2018)

    Table Global Oral Thin Film Drugs Sales Market Share (%) by Regions (2013-2018)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) by Regions (2013-2018)

    Figure 2017 Global Oral Thin Film Drugs Sales Market Share (%) by Regions

    Table Global Oral Thin Film Drugs Revenue (Million USD) by Regions (2013-2018)

    Table Global Oral Thin Film Drugs Revenue Market Share (%) by Regions (2013-2018)

    Figure Global Oral Thin Film Drugs Revenue Market Share (%) by Regions (2013-2018)

    Figure 2017 Global Oral Thin Film Drugs Revenue Market Share (%) by Regions

    Table Global Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure North America Oral Thin Film Drugs Sales Growth Rate

    Table North America Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure United States Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure United States Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Canada Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Canada Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Mexico Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Mexico Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Europe Oral Thin Film Drugs Sales Growth Rate

    Table Europe Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Germany Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Germany Oral Thin Film Drugs Revenue (Million USD) (2013-2018)

    Figure UK Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure UK Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure France Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure France Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Italy Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Italy Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Russia Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Russia Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Turkey Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Turkey Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Asia-Pacific Oral Thin Film Drugs Sales Growth Rate

    Table Asia-Pacific Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure China Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure China Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Japan Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Japan Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Korea Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Korea Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Southeast Asia Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Southeast Asia Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Indonesia Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Indonesia Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Thailand Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Thailand Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Malaysia Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Malaysia Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Philippines Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Philippines Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Vietnam Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Vietnam Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure India Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure India Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Australia Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Australia Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure South America Oral Thin Film Drugs Sales Growth Rate

    Table South America Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure Brazil Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure Brazil Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Middle East and Africa Oral Thin Film Drugs Sales Growth Rate

    Table Middle East and Africa Oral Thin Film Drugs Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)

    Figure North Africa Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure North Africa Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure GCC Countries Oral Thin Film Drugs Sales (K Doses)(2013-2018)

    Figure GCC Countries Oral Thin Film Drugs Revenue (Million USD)(2013-2018)

    Figure Schizophrenia Examples

    Figure Migraine Examples

    Figure Opioid Dependence Examples

    Figure Nausea & Vomiting Examples

    Figure Others Examples

    Table Global Oral Thin Film Drugs Sales (K Doses) Comparison by Application (2013-2025)

    Table Global Oral Thin Film Drugs Sales (K Doses) by Application (2013-2018)

    Table Global Oral Thin Film Drugs Sales Share (%) by Application (2013-2018)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) by Application (2013-2018)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) by Application in 2017

    Figure Global Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Global Oral Thin Film Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)

    Table Global Oral Thin Film Drugs Sales (K Doses) Forecast by Regions (2018-2025)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) Forecast by Regions (2018-2025)

    Figure North America Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure North America Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Europe Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Europe Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Asia-Pacific Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Asia-Pacific Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure China Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure China Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Japan Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Japan Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Korea Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Korea Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Southeast Asia Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Southeast Asia Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure India Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure India Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Australia Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Australia Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure South America Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure South America Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure Middle East and Africa Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure Middle East and Africa Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure North Africa Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure North Africa Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Figure GCC Countries Oral Thin Film Drugs Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)

    Figure GCC Countries Oral Thin Film Drugs Revenue and Growth Rate (%) Forecast (2018-2025)

    Table Global Oral Thin Film Drugs Sales (Million USD) Forecast by Type (2018-2025)

    Figure Global Oral Thin Film Drugs Sales Market Share (%) Forecast by Type (2018-2025)

    Table Global Oral Thin Film Drugs Revenue (Million USD) Forecast by Type (2018-2025)

    Figure Global Oral Thin Film Drugs Revenue Market Share (%) Forecast by Type (2018-2025)

    Figure Sublingual Film Sales Growth Forecast

    Figure Fully Dissolving Dental/Buccal Film Sales Growth Forecast

    Table Global Oral Thin Film Drugs Sales (K Doses) Forecast by Application (2018-2025)

    Figure Global Oral Thin Film Drugs Sales Forecast by Application (2018-2025)

    Figure Global Oral Thin Film Drugs Sales (K Doses) Forecast in Schizophrenia

    Figure Global Oral Thin Film Drugs Sales (K Doses) Forecast in Migraine

    Table Key Raw Materials Lists

    Figure Key Raw Materials Price

    Table Raw Materials Key Suppliers Lists

    Figure Oral Thin Film Drugs Manufacturing Cost Structure

    Figure Oral Thin Film Drugs Industrial Chain Analysis

    Table Distributors List

    Table Oral Thin Film Drugs Downstream Customers

null
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>